Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Anja Thronicke"'
Publikováno v:
Cancers, Vol 16, Iss 8, p 1609 (2024)
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small-cell lung cancer (NSCLC). Results of a real-world data study investigating add-on VA (Viscum album L.) to chemotherapy have s
Externí odkaz:
https://doaj.org/article/e8668a94d6e148188bd6a22b3254cc0b
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Lung cancer (LC) is associated with high mortality and poor quality of life (QoL). The disease as well as oncological treatments such as radiation and chemotherapy with adverse effects can impair the QoL of patients. Add-on treatm
Externí odkaz:
https://doaj.org/article/6fed87d2ce7147c09bed4977eca6f2f2
Self-Reported Baseline Quality of Life Mirrors Treatment-Specific Characteristics of Cancer Patients
Autor:
Anja Thronicke, Shiao Li Oei, Gerrit Grieb, Patricia Grabowski, Juliane Roos, Friedemann Schad
Publikováno v:
Cancers, Vol 15, Iss 24, p 5763 (2023)
Background: Baseline quality of life (bQL) has been shown to be a predictor of the clinical outcome of oncological patients. The primary objective of the present study was to examine the role of bQL as a treatment predictor in oncological patients. M
Externí odkaz:
https://doaj.org/article/d16cebfd9a3c4cf6bcae6a3531e10c4a
Autor:
Shiao Li Oei, Anja Thronicke, Jessica Groß, Thomas Rieser, Sarah Becker, Patricia Grabowski, Gerrit Grieb, Harald Matthes, Friedemann Schad
Publikováno v:
Cancers, Vol 15, Iss 23, p 5678 (2023)
Background: Chronic cancer-related fatigue is difficult to manage in breast cancer survivors. The tango trial showed that a six-week tango Argentino program was effective in reducing fatigue and improving quality of life, and here we investigated the
Externí odkaz:
https://doaj.org/article/2fbb0728d4a64e5e9d81a109d2ccbc5e
Autor:
Shiao Li Oei, Thomas Rieser, Sarah Becker, Jessica Groß, Harald Matthes, Friedemann Schad, Anja Thronicke
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background The majority of breast cancer patients suffer from persistent impairments after completion of their primary oncological therapy. Cancer-related fatigue (CRF) in particular is a multidimensional syndrome having a profound negative
Externí odkaz:
https://doaj.org/article/58fd5e2eb30e4204a9b80200a8c55257
Autor:
Friedemann Schad, Thomas Rieser, Sarah Becker, Jessica Groß, Harald Matthes, Shiao Li Oei, Anja Thronicke
Publikováno v:
Cancers, Vol 15, Iss 11, p 2920 (2023)
Background: Persistent impairments of quality of life—in particular, cancer-associated fatigue—are a major limitation for breast cancer survivors. As physical activity and mindfulness interventions have been shown to be effective in reducing fati
Externí odkaz:
https://doaj.org/article/cfcf9e47c5b44c98af5ade3b0b517a0c
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0277880 (2022)
IntroductionIrritable bowel syndrome (IBS) is characterized by patients' high level of suffering. Up to 60% of patients with IBS have symptoms of anxiety or depression and only little attention has been paid to their specific requirements. Anthroposo
Externí odkaz:
https://doaj.org/article/115120f104024452a6198a8ad916409f
Autor:
Friedemann Schad, Anja Thronicke, Megan L Steele, Antje Merkle, Burkhard Matthes, Christian Grah, Harald Matthes
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273387 (2022)
[This corrects the article DOI: 10.1371/journal.pone.0203058.].
Externí odkaz:
https://doaj.org/article/c348bea5b36e4092ae63c4950a661e2f
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Introduction: Cancer-related fatigue (CRF) occurs frequently in breast cancer patients. The aim of this real-world study was to analyze the longitudinal changes of CRF in breast cancer patients receiving an integrative medicine program, which include
Externí odkaz:
https://doaj.org/article/41d610addce3479eb92992bdc0cff4ac
Autor:
Anja Thronicke PhD, Burkhard Matthes MD, Philipp von Trott MD, Friedemann Schad MD, Christian Grah MD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Background: Recent data suggest a beneficial effect of add-on treatment with Viscum album L (VA) on the survival in cancer patients. The objective of this study was to compare the impact of standard oncological therapy plus add-on VA treatment (S+VA)
Externí odkaz:
https://doaj.org/article/1d868b50b2204abda1ee381cd7a2df49